Generic HIV/AIDS medications are less expensive but may also be less effective, says a new study from researchers at Massachusetts General Hospital. In an extensive trial, the researchers administered a generic replacement for the standard treatment Atripla.
It takes three generic drugs, tenofovir (Viread), emtricitabine (Emtriva) and efavirenz (Sustiva), to replace the medicine found in one Atripla pill. Each patient in the trial took all three medications and researchers found, on average, those taking the premium pill saved roughly 4.4 months of life.
The trade off, however, is that the generic drugs saved roughly $42,500 per patient:
"This is a trade-off that many of us will find emotionally difficult, and perhaps even ethically impossible, to recommend," said lead researcher Dr Rochelle Walensky.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org